Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
M3 ( (JP:2413) ) just unveiled an announcement.
M3, Inc. announced the repurchase of 227,500 of its own common shares, amounting to 477,926,850 yen, conducted through open market purchases on the Tokyo Stock Exchange in August 2025. This move is part of a larger plan approved by the Board of Directors to buy back up to 20 million shares, with a maximum expenditure of 20 billion yen, aimed at optimizing capital structure and enhancing shareholder value.
The most recent analyst rating on (JP:2413) stock is a Hold with a Yen2300.00 price target. To see the full list of analyst forecasts on M3 stock, see the JP:2413 Stock Forecast page.
More about M3
M3, Inc. operates in the healthcare industry, focusing on providing medical-related services and products. The company is listed on the Tokyo Stock Exchange and is involved in various healthcare solutions, including online medical services and platforms.
Average Trading Volume: 3,736,553
Technical Sentiment Signal: Hold
Current Market Cap: Yen1575.4B
Find detailed analytics on 2413 stock on TipRanks’ Stock Analysis page.

